Constitutive overexpression of prostaglandin H synthase-2 in benign and malignant tumors in mouse skin in vivo

1995 ◽  
Vol 121 (S1) ◽  
pp. A28-A28
Author(s):  
K. Scholz ◽  
K. Müller-Decker ◽  
F. Marks ◽  
G. Fürstenberger
1995 ◽  
Vol 309 (1) ◽  
pp. 263-269 ◽  
Author(s):  
K Scholz ◽  
G Fürstenberger ◽  
K Müller-Decker ◽  
F Marks

Normal mouse epidermis constitutively expresses prostaglandin-H synthase 1 (PGHS-1) but no PGHS-2. Acute inflammation and epidermal hyperplasia, (hyperplastic transformation), as evoked in adult mouse skin in vivo by wounding or by the phorbol ester phorbol 12-myristate 13-acetate (PMA), resulted in a transient induction of PGHS-2 expression while PGHS-1 remained unchanged. Under conditions of a stationary epidermal hyperplasia, as in neonatal mouse epidermis, PGHS-1, but not PGHS-2, expression was observed. Induction of ‘balanced hyperproliferation’ by 4-O-methyl-phorbol 12-myristate 13-acetate (4-O-methyl-PMA) did not lead to PGHS-2 expression. When keratinocytes were isolated from neonatal mouse skin and separated by Percoll density-gradient centrifugation according to their stage of differentiation, PGHS-1 mRNA expression and protein were found to be highest in the differentiated cells compared with those from the proliferative compartment. A similar distribution of PGHS-1 mRNA was found in keratinocytes from adult mice, whereas PGHS-1 protein was equally distributed in all cell types. Contrary to the situation in intact epidermis, PGHS-2 mRNA but no protein was detected in all cell fractions. Established keratinocyte lines constitutively expressed both isoenzymes at different ratios. In the mouse line MSCP5 an almost exclusive expression of PGHS-2 was found, which was further enhanced by PMA treatment. These data indicate that the expression of PGHS-2 in mouse epidermis is specifically related to the emergency reaction of hyperplastic transformation.


1995 ◽  
Vol 121 (S1) ◽  
pp. A18-A18
Author(s):  
K. Müller-Decker ◽  
K. Scholz ◽  
F. Marks ◽  
G. Fürstenberger

1998 ◽  
Vol 242 (1) ◽  
pp. 84-91 ◽  
Author(s):  
K. Müller-Decker ◽  
K. Scholz ◽  
G. Neufang ◽  
F. Marks ◽  
G. Fürstenberger

2002 ◽  
Vol 87 (6) ◽  
pp. 2816-2823 ◽  
Author(s):  
Renée F. Johnson ◽  
Carolyn M. Mitchell ◽  
Warwick B. Giles ◽  
William A. Walters ◽  
Tamas Zakar

1985 ◽  
Vol 6 (9) ◽  
pp. 1379-1387 ◽  
Author(s):  
Y. Yamazoe ◽  
D.W. Miller ◽  
C.C. Weis ◽  
K.L. Dooley ◽  
T.V. Zenser ◽  
...  

2020 ◽  
Vol 13 (10) ◽  
pp. 265
Author(s):  
Alexey Goltsov ◽  
Maciej Swat ◽  
Kirill Peskov ◽  
Yuri Kosinsky

The kinetic model of Prostaglandin H Synthase-1 (PGHS-1) was developed to investigate its complex network kinetics and non-steroidal anti-inflammatory drugs (NSAIDs) efficacy in different in vitro and in vivo conditions. To correctly describe the complex mechanism of PGHS-1 catalysis, we developed a microscopic approach to modelling of intricate network dynamics of 35 intraenzyme reactions among 24 intermediate states of the enzyme. The developed model quantitatively describes interconnection between cyclooxygenase and peroxidase enzyme activities; substrate (arachidonic acid, AA) and reducing cosubstrate competitive consumption; enzyme self-inactivation; autocatalytic role of AA; enzyme activation threshold; and synthesis of intermediate prostaglandin G2 (PGG2) and final prostaglandin H2 (PGH2) products under wide experimental conditions. In the paper, we provide a detailed description of the enzyme catalytic cycle, model calibration based on a series of in vitro kinetic data, and model validation using experimental data on the regulatory properties of PGHS-1. The validated model of PGHS-1 with a unified set of kinetic parameters is applicable for in silico screening and prediction of the inhibition effects of NSAIDs and their combination on the balance of pro-thrombotic (thromboxane) and anti-thrombotic (prostacyclin) prostaglandin biosynthesis in platelets and endothelial cells expressing PGHS-1.


1998 ◽  
Vol 242 (1) ◽  
pp. 29-32 ◽  
Author(s):  
Clara R Thore ◽  
Tracy C Beasley ◽  
David W Busija

Sign in / Sign up

Export Citation Format

Share Document